Monthly Communication Report

Organization:	Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration:	957857-371-123
Communication date:	2025-07-30
Posted date:	2025-08-13

Designated Public Office Holders who participated in the communication:	Mackenzy  Metcalfe, Policy Advisor Office of the Minister of Finance, Finance Canada (FIN)
List of Details Subject matter Detail Federal-Provincial Relations, Foreign Affairs, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance Proposed pharmacare legislation related to any future national pharmacare program
Responsible Officer who filed this communication report:	Bettina Hamelin
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.